Workflow
Genetic Technologies(GENE)
icon
Search documents
Genetic Technologies(GENE) - 2021 Q4 - Annual Report
2021-08-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR (Address of principal executive offices) Simon Morriss, Chief Executive O ...
Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript
2021-01-28 03:28
Genetic Technologies Limited (NASDAQ:GENE) Quarterly Investor Webinar January 27, 2021 7:30 PM ET Company Participants Stephanie Ottens - Investor Relations George Muchnicki - Acting Chief Executive Officer Peter Rubinstein - Chairman Richard Allman - Chief Scientific Officer Conference Call Participants Stephanie Ottens Good morning and welcome everyone to Genetic Technologies Quarterly Investor Webinar. And we have the pleasure this morning to have from Genetic, Dr. George Muchnicki, Acting CEO on the res ...
Genetic Technologies(GENE) - 2020 Q4 - Annual Report
2020-10-22 17:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F [ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR [ ] SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC ...
Genetic Technologies(GENE) - 2019 Q4 - Annual Report
2019-10-03 18:39
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . Commission file number 000-51504 GENETIC TECHNOLOGIES LIMITED FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g ...